Sjogrens is a hot area in drug development: “Sjogren’s Syndrome Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs, including:
nipocalimab
VAY736 (ianalumab)
HZN-1116
AMG 329
R-2487 https://t.co/sVbyPLi2Um https://t.co/2URpGUsMk9
Links:
Sjogren’s Syndrome Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, …
https://buff.ly/ucJRICC
02-01-2026
